Literature DB >> 16713829

The use of vascularized grafts from the distal radius for the treatment of Preiser's disease.

Steven L Moran1, William P Cooney, Alex Y Shin.   

Abstract

PURPOSE: To examine the outcome of vascularized bone grafts (VBGs) used for the treatment of Preiser's disease.
METHODS: Over a 10-year period (1993-2003) 8 pedicled VBGs were performed as the primary treatment for Preiser's disease. All patients had preoperative magnetic resonance imaging (MRI) scans that confirmed the diagnosis of avascular necrosis of the scaphoid. Bone revascularization was evaluated by examining preoperative and postoperative MRIs. All patients had a reverse-flow pedicled VBG from the distal radius. The average patient age was 40 years and the mean follow-up period was 36 months. Postoperative evaluation included range of motion, grip strength, pain evaluation, and Mayo wrist scores.
RESULTS: All MRIs showed evidence of revascularization, with improvement in T2 and/or T1 signal; however, a consistent finding on MRI was incomplete revascularization of the entire proximal pole. Wrist motion averaged 55% of the unaffected side after surgery. Grip strength remained stable. Seven patients had long-term improvement in pain. The average Mayo wrist score was 68, with 1 patient rated as excellent, 1 as good, 5 as fair, and 1 as poor. There was 1 reconstructive failure that resulted in a proximal row carpectomy less than 1 year after the surgery.
CONCLUSIONS: In this series VBGs led to reduced pain levels and preserved the radiocarpal wrist motion in most patients. Inability to revascularize the proximal pole of the scaphoid and ongoing wrist arthritis appear to persist despite revascularization attempts. VBGs for Preiser's disease should be limited to patients with early stage disease (Herbert stages I or II) without evidence of radiocarpal arthritis and no evidence of carpal instability. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic, Level IV.

Entities:  

Mesh:

Year:  2006        PMID: 16713829     DOI: 10.1016/j.jhsa.2006.02.002

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  9 in total

1.  Vascularized bone grafts and their applications in the treatment of carpal pathology.

Authors:  Marco Rizzo; Steven L Moran
Journal:  Semin Plast Surg       Date:  2008-08       Impact factor: 2.314

2.  Bilateral Preiser Disease in a Patient with Sickle Cell Anemia.

Authors:  Joseph Catapano; Oluwatola O Overduin; Herbert P von Schroeder
Journal:  J Hand Microsurg       Date:  2020-08-10

3.  Avascular Necrosis of the Scaphoid Preiser Disease.

Authors:  Femke M A P Claessen; Ilse Schol; Gregory P Kolovich; David Ring
Journal:  Arch Bone Jt Surg       Date:  2020-01

4.  Vascularized bone grafts for the treatment of carpal bone pathology.

Authors:  Brian M Derby; Peter M Murray; Alexander Y Shin; Reuben A Bueno; Christophe L Mathoulin; Tim Ade; Michael W Neumeister
Journal:  Hand (N Y)       Date:  2013-03

5.  Treatment of Preiser disease with vascularized bone graft from the distal radius: a report of two cases.

Authors:  Sérgio Augusto Machado da Gama; Marcelo Rosa de Rezende; Samuel Ribak
Journal:  Hand (N Y)       Date:  2015-09

6.  Preiser disease after repeated local glucocorticoid injections: A case report.

Authors:  Yuji Tomori; Norio Motoda; Ryuji Ohashi; Takuya Sawaizumi; Mitsuhiko Nanno; Shinro Takai
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

7.  Carpal Collapse After Scaphoid Nonunion: A Novel Combined Approach to the 1,2 Intercompartmental Supraretinacular Artery Radial Flap.

Authors:  Konstantinos A Vakalopoulos; Nicolas Balagué; Philippe Vostrel; Sana Boudabbous; Jean-Yves Beaulieu
Journal:  J Hand Surg Glob Online       Date:  2020-04-10

8.  Preiser disease in a child before complete ossification of the scaphoid: a case report.

Authors:  Taketsugu Fujibuchi; Hiroshi Imai; Akihiro Jono; Hiroshi Kiyomatsu; Hiromasa Miura
Journal:  BMC Musculoskelet Disord       Date:  2022-03-18       Impact factor: 2.362

9.  Clinical outcomes of nonsurgical treatment for Preiser disease.

Authors:  Yuji Tomori; Mitsuhiko Nanno; Shinro Takai
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.